Article

Enhanced CT Protocol Could Improve Diagnosis of Acute Chest Pain

A recent study found the addition of LCE CT reportedly bolsters the diagnosis rate among patients with acute chest pain who have negative findings on TRO CT.

This article was originally published on DiagnosticImaging.com.

New research from investigators in Italy suggests use of a multiparametric computed tomography (CT) protocol, including late contrast enhancement (LCE) CT, could improve the diagnosis of troponin-positive acute chest pain.

In the study, published online in Radiology, the use of triple-rule-out (TRO) CT diagnosed half of the 84 patients in the study with 35 patients being diagnosed with obstructive coronary artery disease (CAD). For the remaining 42 patients who had negative findings with TRO CT, the study authors obtained a LCE CT scan. This led to a diagnosis in 34 of those patients, including 22 patients diagnosed with myocarditis. In other words, the use of LCE CT improved the initial diagnosis rate of TRO CT from 50 percent (42 of 84 patients) to 90 percent (76 of 84 patients).

“Troponin-positive chest pain with unobstructed coronary arteries represents a diagnostic dilemma, and the identification of its cause is of pivotal importance for the management, treatment, and prognostication of patients,” wrote Anna Palmisano, M.D., who is affiliated with the Clinical and Experimental Radiology Unit in the Experimental Imaging Center at the IRCCS San Raffaele Scientific Institute in Milan, Italy, and colleagues. “ … In our study, LCE CT provided a diagnosis in 81 percent of participants with negative findings at TRO CT (34 of 42), similar to what has previously been reported for cardiac MRI.”

The study authors said the findings demonstrate a “significant improvement in CT capability” to achieve a definitive diagnosis for patients with acute chest pain. Palmisano and colleagues also suggested in the study that implementation of the aforementioned CT protocol could result in a quicker diagnosis because it enables radiologists to employ a single CT study to obtain “several pieces of information commonly derived from combined CT and MRI examinations.”

Limitations of the study included a limited contrast-to-noise ratio (CNR) and small increase in radiation exposure associated with the use of LCE CT as well as a limited patient sample size, according to the study authors. They suggested that larger trials are necessary to assess the cost-effectiveness and clinical value of the study’s CT protocol.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.